Phase 2 study for people with Bladder Cancer

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 15 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Pfizer
Registry number NCT07421700
Started 11 March 2026 Today 16 October 2026 Estimated completion 28 December 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Macquarie University North Ryde NSW Recruiting
Icon Cancer Centre Wesley Auchenflower QLD Recruiting
Monash Health Clayton VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 132

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Age ≥18 years at the time of screening.

* Histologically confirmed locally advanced or metastatic urothelial carcinoma (LA/mUC).

* Measurable disease per RECIST v1.1 criteria.

* ECOG performance status of 0 or 1.

* Adequate organ function, including hematologic, hepatic, and renal parameters.

* Willingness to comply with study procedures and provide informed consent.

* For participants of childbearing potential: agreement to use effective contraception during the study and for a defined period after the last dose.

Exclusion Criteria:

Participants will be excluded if they meet any of the following:

* History of another malignancy within 3 years before the first dose of study intervention, or any evidence of residual disease from a previously diagnosed malignancy

* Known active CNS lesions, including leptomeningeal metastasis, brainstem, meningeal, or spinal cord metastases or compression

* Active autoimmune diseases requiring systemic treatment within the past 2 years

* Participation in another investigational study within 30 days or 5 half-lives of the investigational product.

* Pregnant or breastfeeding individuals.

* Inability or unwillingness to comply with study requirements.

* Study staff or their immediate family members directly involved in the conduct of the study.

Dates on the record

Started 11 March 2026
Estimated completion 28 December 2027
Registry last updated 8 October 2026
Checked by Voxsanity 15 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 8 October 2026.
  • This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.